Literature DB >> 20423311

Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.

S Majumdar1, B C Mohanta, D R Chowdhury, R Banik, B Dinda, A Basak.   

Abstract

BACKGROUND: Proprotein Convertases (PCs) or Proprotein Convertase Subtilisin/Kexins (PCSKs) belong to a family of calcium-dependent endoproteases that are structurally related to bacterial subtilisin and yeast kexin. These enzymes play major roles in the processing of inactive precursor proteins producing their bioactive mature forms that are implicated in a wide variety of diseases including cancer, viral and bacterial infections. As a result, PCs are major targets for intervention of these diseases.
OBJECTIVE: Our objective in this study is to find non-peptide inhibitors of PC-enzymes from a potential natural source.
RESULTS: Herein we describe several natural flavonoid compounds as inhibitors of PC-enzymes including furin, a key member. These compounds were isolated from the medicinal plant Oroxylum indicum, fully characterized and tested in vitro for their PC-inhibitory property against the fluorogenic peptide substrate, Boc-RVRR-MCA (Boc = tert-butyloxy carbonyl, MCA = 4-methyl coumarin7-amide). The measured Ki and IC50 were found to be in low microM ranges. A comparative analysis of inhibition against furin, PC4, PC5 and PC7 suggested a partial selectivity towards PC4. These flavonoids also blocked efficiently the PC4-mediated processing of a fluorogenic peptide derived from the processing site of its substrate, pro-Insulin Growth Factor-1 (proIGF-1). This anti-protease activity may provide a rationale for the observed anticancer and anti-HIV properties of some of these flavonoid compounds. This is the first demonstration of anti-PC activity of flavonoid compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423311     DOI: 10.2174/092986710791233643

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

Review 1.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

Review 2.  The Role of Proprotein Convertases in Upper Airway Remodeling.

Authors:  Sang-Nam Lee; Joo-Heon Yoon
Journal:  Mol Cells       Date:  2022-06-30       Impact factor: 4.250

Review 3.  Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections.

Authors:  Qiongqiong Angela Zhou; Junko Kato-Weinstein; Yingzhu Li; Yi Deng; Roger Granet; Linda Garner; Cynthia Liu; Dmitrii Polshakov; Chris Gessner; Steven Watkins
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-30

Review 4.  Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.

Authors:  Kara Fitzgerald
Journal:  Perm J       Date:  2020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.